JAVMA news
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during the Executive Board…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
JAVMA news
Policy addresses therapeutic use of stem cells, regenerative medicine
The AVMA House of Delegates passed a new policy July 21 on "Therapeutic Use of Stem Cells and Regenerative Medicine."
JAVMA news
Horse deaths associated with unapproved drug
An unapproved clenbuterol product associated with two horse deaths in Louisiana has prompted the FDA to remind veterinarians and horse
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
JAVMA news
A closer look at veterinary homeopathy
Homeopathy is, depending on whom you ask, a gentler and more natural alternative to traditional medicine or an unproven and useless modality, at best.
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
JAVMA news
Concentration labeling changed for epinephrine, two other medications
Three human-use pharmaceuticals used in veterinary medicine will be sold with labels containing revised descriptions of drug concentrations.
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
JAVMA news
Reminder: ECP not approved for use in animals
The Food and Drug Administration's Center for Veterinary Medicine has received reports that certain pharmacies and veterinarians have compounded…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
JAVMA news
The truth about serum
The anesthesia team is transfusing the patient with plasma believed to contain normal to high protein concentrations.
JAVMA news
WHO seeks end to antibiotic use without disease
Global health authorities are discouraging use of antimicrobials in food-producing animals in the absence of disease.
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Monograph on macrocyclic lactones released
The U.S. Pharmacopeia has released a free monograph on macrocyclic lactones.
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
Delegates discuss ethics of vendor incentive programs
The Principles of Veterinary Medical Ethics of the AVMA adequately cover transparency in acceptance of sponsorships, rebates, equipment, and free…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
FDA seeks comment on Animal Drug User Fee Act
The Food and Drug Administration is seeking comment on the Animal Drug User Fee Act regarding the program's performance and reauthorization.
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…